Size Doesn’t Matter: A Small Biotech Plays Big with Payer Engagement
The complex, costly, and continuously evolving arena of biopharmaceutical product development demands a constant eye on commercialization potential. Continue Reading
patti peeples
Educating the Next Leaders in Applied HEOR: Jefferson’s Unique Approach
In this blog, Dr. Peeples interviews Dr. Vittorio Maio, Jefferson’s AHEOR Program Director and they discuss how his team has devised a curriculum and an online experience that enables working professionals to enhance their career while maintaining their full-time job. Continue Reading
Payer Contact in a “Contactless” World: Achieving Early Engagement
In the first of a two-part series on early engagement with payers, Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Allen Lising, Managing Director of FormularyDecisions at Xcenda to discusss this innovative platform. Continue Reading
Transforming legacy approaches to understanding drug costs: An Interview with HealthPlanView’s Nicole Espinoza
Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Nicole Espinoza, Vice President of Knowledge Management at Pharmspective, a Healthcare Knowledge Management Company and the organization behind a new platform, HealthPlanView™, designed to address transparency around the true patient cost… Continue Reading
Real-world evidence and value-based contracting – swipe left or swipe right?
As biopharma makes the shift toward a personalized healthcare system, it is also transitioning towards a pipeline full of innovative, high-cost therapies. We are moving to a value-based system, with two of the biggest ideas for this decade becoming more… Continue Reading
